Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,168,519 papers from all fields of science
Search
Sign In
Create Free Account
NY 198
Known as:
NY-198
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
lomefloxacin
lomefloxacin hydrochloride
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1989
1989
In vitro activities of lomefloxacin and temafloxacin against pathogens causing diarrhea
J. Segreti
Antimicrobial Agents and Chemotherapy
1989
Corpus ID: 44454306
The in vitro activities of temafloxacin (A63004) and lomefloxacin (SC-47111; NY-198) were compared with those of seven other…
Expand
1989
1989
Lomefloxacin, a new fluoroquinolone. Studies on in vitro antimicrobial spectrum, potency, and development of resistance.
K. Aldridge
,
A. Henderberg
,
Kathleen Gebbia
,
D. Schiro
,
A. Janney
,
Charles V. Sanders
Diagnostic microbiology and infectious disease
1989
Corpus ID: 22518303
1989
1989
Intraocular dynamic mode differences of new quinolone antibacterial agents between pigmented and albino rabbit eyes.
M. Fukuda
,
K. Sasaki
Lens and eye toxicity research
1989
Corpus ID: 25124180
The influence of melanin on the intraocular dynamics of a new quinolone anti-bacterial agent, NY-198, was investigated in albino…
Expand
Highly Cited
1988
Highly Cited
1988
In vitro activity of lomefloxacin, a new quinolone antimicrobial agent, in comparison with those of other agents
R. Wise
,
J. Andrews
,
J. Ashby
,
R S Matthews
Antimicrobial Agents and Chemotherapy
1988
Corpus ID: 9417261
The in vitro activity of lomefloxacin (SC-47111; NY-198), a new difluorinated quinolone, was compared with those of ofloxacin…
Expand
1988
1988
In vitro activities of T-3262, NY-198, fleroxacin (AM-833; RO 23-6240), and other new quinolone agents against clinically isolated Chlamydia trachomatis strains
H. Maeda
,
A. Fujii
,
K. Nakata
,
S. Arakawa
,
S. Kamidono
Antimicrobial Agents and Chemotherapy
1988
Corpus ID: 38208204
The in vitro activities of three newly developed quinolone drugs (T-3262, NY-198, and fleroxacin [AM-833; RO 23-6240]) against 10…
Expand
1988
1988
Enterohepatic circulation of NY-198, a new difluorinated quinolone, in rats
A. Saito
,
O. Nagata
,
Y. Takahara
,
E. Okezaki
,
T. Yamada
,
Y. Ito
Antimicrobial Agents and Chemotherapy
1988
Corpus ID: 2837770
Enterohepatic circulation of NY-198 in rats was studied. NY-198 glucuronide in the bile was rapidly hydrolyzed to NY-198 by the…
Expand
1988
1988
Comparative antibacterial activity of new quinolone-carboxylic acid derivatives.
S. Mitsuhashi
Reviews of Infectious Diseases
1988
Corpus ID: 34475233
In vitro and in vivo antibacterial activities of new quinolone-carboxylic acid derivatives are described. A compilation of MICs…
Expand
1988
1988
In vitro activities of ofloxacin and four other new quinoline-carboxylic acids against Chlamydia trachomatis
A. Nagayama
,
T. Nakao
,
H. Taen
Antimicrobial Agents and Chemotherapy
1988
Corpus ID: 39785438
The in vitro activities of five new quinoline-carboxylic acids against 2 reference strains and 45 clinical isolates of Chlamydia…
Expand
1988
1988
Efficacy of NY-198 against experimental Legionnaires disease
S. Kohno
,
K. Yamaguchi
,
+5 authors
K. Hara
Antimicrobial Agents and Chemotherapy
1988
Corpus ID: 29357983
The in vitro and in vivo effects of NY-198 against Legionella pneumophila were compared with those of ciprofloxacin. The MIC of…
Expand
Highly Cited
1987
Highly Cited
1987
In vitro and in vivo activity of NY-198, a new difluorinated quinolone
Tohru Hirose
,
Eiichi
,
Okezaki
,
Hideo Kato
,
Yasuo Ito
,
Matsuhisa Inoue
Antimicrobial Agents and Chemotherapy
1987
Corpus ID: 24872281
NY-198 [1-ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3- quinolinecarboxylic acid hydrochloride] is a new…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE